| Literature DB >> 30923224 |
Ben C Scheele1,2,3, Frank Pasmans4, Lee F Skerratt3, Lee Berger3, An Martel4, Wouter Beukema4, Aldemar A Acevedo5,6, Patricia A Burrowes7, Tamilie Carvalho8, Alessandro Catenazzi9, Ignacio De la Riva10, Matthew C Fisher11, Sandra V Flechas12,13, Claire N Foster14, Patricia Frías-Álvarez3, Trenton W J Garner15,16, Brian Gratwicke17, Juan M Guayasamin18,19,20, Mareike Hirschfeld21, Jonathan E Kolby3,22,23, Tiffany A Kosch3,24, Enrique La Marca25, David B Lindenmayer14,2, Karen R Lips26, Ana V Longo27, Raúl Maneyro28, Cait A McDonald29, Joseph Mendelson30,31, Pablo Palacios-Rodriguez12, Gabriela Parra-Olea32, Corinne L Richards-Zawacki33, Mark-Oliver Rödel21, Sean M Rovito34, Claudio Soto-Azat35, Luís Felipe Toledo8, Jamie Voyles36, Ché Weldon16, Steven M Whitfield37,38, Mark Wilkinson39, Kelly R Zamudio29, Stefano Canessa4.
Abstract
Anthropogenic trade and development have broken down dispersal barriers, facilitating the spread of diseases that threaten Earth's biodiversity. We present a global, quantitative assessment of the amphibian chytridiomycosis panzootic, one of the most impactful examples of disease spread, and demonstrate its role in the decline of at least 501 amphibian species over the past half-century, including 90 presumed extinctions. The effects of chytridiomycosis have been greatest in large-bodied, range-restricted anurans in wet climates in the Americas and Australia. Declines peaked in the 1980s, and only 12% of declined species show signs of recovery, whereas 39% are experiencing ongoing decline. There is risk of further chytridiomycosis outbreaks in new areas. The chytridiomycosis panzootic represents the greatest recorded loss of biodiversity attributable to a disease.Mesh：
Year: 2019 PMID： 30923224 DOI： 10.1126/science.aav0379
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728